Min Kyeong Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Min Kyeong Lee has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Joo Kyung Noh
Department of Biomedical Science and Technology, Graduate School, Kyung Hee University, Seoul, Republic of Korea. 1
24 shared publications - Moonkyoo Kong
Division of Lung & Head and Neck Oncology, Department of Radiation Oncology, Kyung Hee University Medical Center, Kyung Hee University College of Medicine
24 shared publications - Seon Rang Woo
Department of Otolaryngology-Head and Neck Surgery, Kyung Hee University School of Medicine, Kyung Hee University Medical Center, Seoul, Korea. 2
24 shared publications - Seong-Gyu Ko
Department of Preventive Medicine, College of Korean Medicine Kyung Hee University Seoul Republic of Korea
24 shared publications - Soonki Min
Department of Radiation Oncology, Kyung Hee University School of Medicine, Kyung Hee University Medical Center, Seoul, Korea. 3
24 shared publications - Young Chan Lee
Department of Otorhinolaryngology-Head and Neck Surgery, School of Medicine, Kyung Hee University, Seoul, Korea
24 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure Legends from Prognostic Significance of SASP-Related Gene Signature of Radiation Therapy in Head and Neck Squamous Cell Carcinoma
Supplementary Figure Legends full
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure Legends from Prognostic Significance of SASP-Related Gene Signature of Radiation Therapy in Head and Neck Squamous Cell Carcinoma
Supplementary Figure Legends full
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Prognostic Significance of SASP-Related Gene Signature of Radiation Therapy in Head and Neck Squamous Cell Carcinoma
Supplementary figure 2. Pathway analysis (A) Pathway analysis of SASP-related gene signature based on Protein–protein interaction network. The PPI confidence score lower than 0.9 and genes in the network with at least 5 degrees were respectively set as significant. Subsequently, the PPI network with scores> 5, node ≥ counts 5, node score = 0.2, and maximum depth = 100 as cut-off criteria. (B) Enrichment pathway of SASP-related gene signature based on GESA analysis. The human-ENSEMBLE-Gene-MsigDB chip was selected as the chip platform. FDR less than 0.05 after 1,000 random permutations were set as the cut-off criterion. (C) TNF-alpha signaling via NF-kappa B was enriched in cluster 1 of SASP-related gene signature (FDR <0.05) and G2M checkpoint enriched in cluster 2 of SASP-related gene signature (FDR <0.05) The enrichment score (y-axis) is shown. The top portion of the plot shows the ES (green line). (D) The ranked list of genes in TNF-alpha signaling via NF-kappa B of cluster1 (Right) and the ranked list of genes in the G2M checkpoint of cluster2 (Left) are shown.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Prognostic Significance of SASP-Related Gene Signature of Radiation Therapy in Head and Neck Squamous Cell Carcinoma
Supplementary figure 2. Pathway analysis (A) Pathway analysis of SASP-related gene signature based on Protein–protein interaction network. The PPI confidence score lower than 0.9 and genes in the network with at least 5 degrees were respectively set as significant. Subsequently, the PPI network with scores> 5, node ≥ counts 5, node score = 0.2, and maximum depth = 100 as cut-off criteria. (B) Enrichment pathway of SASP-related gene signature based on GESA analysis. The human-ENSEMBLE-Gene-MsigDB chip was selected as the chip platform. FDR less than 0.05 after 1,000 random permutations were set as the cut-off criterion. (C) TNF-alpha signaling via NF-kappa B was enriched in cluster 1 of SASP-related gene signature (FDR <0.05) and G2M checkpoint enriched in cluster 2 of SASP-related gene signature (FDR <0.05) The enrichment score (y-axis) is shown. The top portion of the plot shows the ES (green line). (D) The ranked list of genes in TNF-alpha signaling via NF-kappa B of cluster1 (Right) and the ranked list of genes in the G2M checkpoint of cluster2 (Left) are shown.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Prognostic Significance of SASP-Related Gene Signature of Radiation Therapy in Head and Neck Squamous Cell Carcinoma
Supplementary Table 3 from Prognostic Significance of SASP-Related Gene Signature of Radiation Therapy in Head and Neck Squamous Cell Carcinoma
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Prognostic Significance of SASP-Related Gene Signature of Radiation Therapy in Head and Neck Squamous Cell Carcinoma
Supplementary Table 3 from Prognostic Significance of SASP-Related Gene Signature of Radiation Therapy in Head and Neck Squamous Cell Carcinoma
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Prognostic Significance of SASP-Related Gene Signature of Radiation Therapy in Head and Neck Squamous Cell Carcinoma
Supplementary Figure 3. Flow cytometry analysis of cell death rates in HSC4.P and HSC4.RR Cell lines after exposure 8 Gy IR.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Prognostic Significance of SASP-Related Gene Signature of Radiation Therapy in Head and Neck Squamous Cell Carcinoma
Supplementary Figure 3. Flow cytometry analysis of cell death rates in HSC4.P and HSC4.RR Cell lines after exposure 8 Gy IR.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Prognostic Significance of SASP-Related Gene Signature of Radiation Therapy in Head and Neck Squamous Cell Carcinoma
Supplementary Figure 1. The accuracy of the model predictions was validated using LOOCV. the training set was used to assess the accuracy of predictions on the validation set.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Prognostic Significance of SASP-Related Gene Signature of Radiation Therapy in Head and Neck Squamous Cell Carcinoma
Supplementary Figure 1. The accuracy of the model predictions was validated using LOOCV. the training set was used to assess the accuracy of predictions on the validation set.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Data from Prognostic Significance of SASP-Related Gene Signature of Radiation Therapy in Head and Neck Squamous Cell Carcinoma
In this study, we developed and validated the clinical significance of senescence-associated secretory phenotype (SASP)-related gene signature and explored its association with radiation therapy (RT) in patients with head and neck squamous cell carcinoma (HNSCC). First, we searched the three published review literature associated with SASP and selected all 81 genes to develop SASP-related gene signature. Then, 81 SASP-related genes were adapted to gene expression dataset from The Cancer Genome Atlas (TCGA). Patients with HNSCC of TCGA were classified into clusters 1 and 2 via unsupervised clustering according to SASP-related gene signature. Kaplan–Meier plot survival analysis showed that cluster 1 had a poorer prognosis than cluster 2 in 5-year overall survival and recurrence-free survival. Similarly, cluster 1 showed a worse prognosis than cluster 2 in three validation cohorts (E-MTAB-8588, FHCRC, and KHU). Cox proportional hazards regression observed that the SASP-related signature was an independent prognostic factor for patients with HNSCC. We also established a nomogram using a relevant clinical parameter and a risk score. Time-dependent receiver operating characteristic analysis was carried out to assess the accuracy of the prognostic risk model and nomogram. Senescence SASP-related gene signature was associated with the response to RT. Therefore, subsequent, in vitro experiments further validated the association between SASP-related gene signature and RT in HNSCC. In conclusion, we developed a SASP-related gene signature, which could predict survival of patients with HNSCC, and this gene signature provides new clinical evidence for the accurate diagnosis and targeted RT of HNSCC.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Prognostic Significance of SASP-Related Gene Signature of Radiation Therapy in Head and Neck Squamous Cell Carcinoma
In this study, we developed and validated the clinical significance of senescence-associated secretory phenotype (SASP)-related gene signature and explored its association with radiation therapy (RT) in patients with head and neck squamous cell carcinoma (HNSCC). First, we searched the three published review literature associated with SASP and selected all 81 genes to develop SASP-related gene signature. Then, 81 SASP-related genes were adapted to gene expression dataset from The Cancer Genome Atlas (TCGA). Patients with HNSCC of TCGA were classified into clusters 1 and 2 via unsupervised clustering according to SASP-related gene signature. Kaplan–Meier plot survival analysis showed that cluster 1 had a poorer prognosis than cluster 2 in 5-year overall survival and recurrence-free survival. Similarly, cluster 1 showed a worse prognosis than cluster 2 in three validation cohorts (E-MTAB-8588, FHCRC, and KHU). Cox proportional hazards regression observed that the SASP-related signature was an independent prognostic factor for patients with HNSCC. We also established a nomogram using a relevant clinical parameter and a risk score. Time-dependent receiver operating characteristic analysis was carried out to assess the accuracy of the prognostic risk model and nomogram. Senescence SASP-related gene signature was associated with the response to RT. Therefore, subsequent, in vitro experiments further validated the association between SASP-related gene signature and RT in HNSCC. In conclusion, we developed a SASP-related gene signature, which could predict survival of patients with HNSCC, and this gene signature provides new clinical evidence for the accurate diagnosis and targeted RT of HNSCC.
- Open Access
- 11 September 2024
- Published by SAGE Publications in Ear, Nose & Throat Journal
Poor Survival of Patients With Very Small But Locally Advanced (T4) Oropharyngeal Cancer
Objective : The size of T4 tumor could vary in oropharyngeal squamous cell carcinoma (OPSCC). Using the Surveillance, Epidemiology, and End Results (SEER) database, this study aimed to investigate the role of tumor size in the prognosis of patients with T4 OPSCC. Study Design: Retrospective cross-sectional. Setting: SEER-Medicare-linked database. Methods: This study enrolled 1153 patients diagnosed with T4 OPSCC from the SEER registry between 2010 and 2016. The primary study variables were tumor size, human papillomavirus (HPV) infection, and disease-specific survival (DSS). Primary tumor size and clinicopathological variables according to HPV status were analyzed using Kaplan–Meier survival curves and Cox proportional hazards regression. Results: The 5-year DSS of patients with HPV-negative T4 OPSCC tumors ≤1 cm was worse than that of patients with tumors >1 cm ( P < .001). The results were consistent even after propensity score matching ( P = .002). Tumors ≤1 cm had a hazard ratio (HR) as high as that of distant metastasis (HR 2.8 vs HR 2.6, P = .006). A decreased DSS of ≤ 1 cm tumors was observed in HPV-negative T4 OPSCC, but not in HPV-positive T4 OPSCC ( P < .001 vs P = .96). Conclusion: A tumor diameter ≤1 cm was associated with poor prognosis in patients with HPV-negative T4 OPSCC. Tumor diameter ≤1 cm could be a predictive factor for poor outcomes in HPV-negative T4 OPSCC.
- 11 September 2024
- Published by SAGE Publications in Ear, Nose & Throat Journal
Open AccessPoor Survival of Patients With Very Small But Locally Advanced (T4) Oropharyngeal Cancer
Objective : The size of T4 tumor could vary in oropharyngeal squamous cell carcinoma (OPSCC). Using the Surveillance, Epidemiology, and End Results (SEER) database, this study aimed to investigate the role of tumor size in the prognosis of patients with T4 OPSCC. Study Design: Retrospective cross-sectional. Setting: SEER-Medicare-linked database. Methods: This study enrolled 1153 patients diagnosed with T4 OPSCC from the SEER registry between 2010 and 2016. The primary study variables were tumor size, human papillomavirus (HPV) infection, and disease-specific survival (DSS). Primary tumor size and clinicopathological variables according to HPV status were analyzed using Kaplan–Meier survival curves and Cox proportional hazards regression. Results: The 5-year DSS of patients with HPV-negative T4 OPSCC tumors ≤1 cm was worse than that of patients with tumors >1 cm ( P < .001). The results were consistent even after propensity score matching ( P = .002). Tumors ≤1 cm had a hazard ratio (HR) as high as that of distant metastasis (HR 2.8 vs HR 2.6, P = .006). A decreased DSS of ≤ 1 cm tumors was observed in HPV-negative T4 OPSCC, but not in HPV-positive T4 OPSCC ( P < .001 vs P = .96). Conclusion: A tumor diameter ≤1 cm was associated with poor prognosis in patients with HPV-negative T4 OPSCC. Tumor diameter ≤1 cm could be a predictive factor for poor outcomes in HPV-negative T4 OPSCC.
- Open Access
- 4 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Prognostic Significance of SASP-Related Gene Signature of Radiation Therapy in Head and Neck Squamous Cell Carcinoma
Supplementary Figure 1. The accuracy of the model predictions was validated using LOOCV. the training set was used to assess the accuracy of predictions on the validation set.
- 4 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Prognostic Significance of SASP-Related Gene Signature of Radiation Therapy in Head and Neck Squamous Cell Carcinoma
Supplementary Figure 1. The accuracy of the model predictions was validated using LOOCV. the training set was used to assess the accuracy of predictions on the validation set.